A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer

Jamunarani Veeraraghavan, Rachel Schiff, Matthew P. Goetz et al.|Annals of Oncology|2019

Cited by 42